Navigation Links
Governor Rendell Appoints Dr. Richard Snyder of Independence Blue Cross to Chronic Care Commission
Date:9/27/2007

izations to help support care.

In addition, the group will seek to increase use of nationally recognized "best practices" for treating chronic disease through pay-for-performance and other incentives to providers -- a concept IBC has long supported through its quality incentive payment system (QIPS). Primary care physicians who participate in the health plan's Keystone Health Plan East HMO provider network may receive additional compensation through QIPS by demonstrating high quality patient care for a number of conditions, including asthma and diabetes.

Additionally, the commission will make technology recommendations for the development of a statewide chronic care information system including a system that will provide insurer claims data to primary care physicians to help target patients' treatment plans.

"I am extremely honored to serve on the Governor's Chronic Care Commission," said Dr. Snyder. "I look forward to working with the many partners from the commission on this important project to help improve the health of Pennsylvanians living with chronic disease."

As IBC's Senior Vice President of Health Services, Snyder has led a number of key initiatives including the implementation of the company's award-winning Connections(SM) Health Management Programs, which provides members 24/7 access to information and support for 22 chronic diseases. An evaluation of the program's second year results completed in 2006 indicated that the Connections(SM) lowered overall medical cost trends by nearly three percent.

Snyder is a member of the American Medical Association, the Pennsylvania Medical Society, the American Academy of Family Physicians, the Pennsylvania Academy of Family Physicians, and the Chester County Medical Society. In addition, Snyder is a member of the National Committee for Quality Assurance (NCQA)'s Review Oversight Committee and America's Health Insurance Plan (AHIP)'s Quality and Industry Standards Workshop.

Snyder
'/>"/>

SOURCE Independence Blue Cross
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Vermont Governor steps in with a new health insurance plan.
2. Arkansas Governor Explains New Health Plan Insurance On Radio Show
3. Massachusetts Governor To Sign Health Coverage Bill
4. Aids Seems More Prevalent Among Goan’s – Governor Visiond
5. Tamil Nadu Emerging As Model State In Public Health Care: Governor
6. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
7. New York Governor to Introduce Bill to Strengthen Abortion Rights
8. Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary
9. Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary
10. Gov. Ed Rendell Plan Would Widen Health Insurance
11. Richard Gere Joins Indian Stars For Fight Against AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...mosomal change that raises odds for malignancy, st... News) -- Some Japanese survivors of the World War...xperienced key genetic changes that may have spark...arch indicates. , Papillary thyroid cancer (PTC...tion involving the so-called BRAF gene. But Japane...
(Date:8/29/2008)...RNewswire/ -- In response to recent news,about Mic...isease (CWD),members of the deer farming communit...ing season fast approaching, the tragic incident r...County farm understandably has,created concern amo...cross,the great state of Michigan. The deer farmin...
(Date:8/29/2008)... to More Than 30 European Countries, HONOLULU, Au...d today,that it has successfully completed the int...ical Device Directive (for most European Union cou...rk -- or Conformite Europeene Mark,-- for the Life...na,s,patient safety reach to include more than 30 ...
(Date:8/29/2008)...presents Telemedicine Encounter Management Systems...ions as a possible solution to national health car...d, MA (PRWEB) August 29, 2008 -- If there has been...s at the Democratic National Convention it has bee...ional health care issues., , ,Our Democratic leade...
Breaking Medicine News(10 mins):Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2
...ability to speak, communicate and relate to others...ence Autism Speaks, a non-profit organization has ... be created on autism. // It was founded in 2005.... between the patients, doctors, researchers and th...
... M.D., and colleagues say that mutation in CCR5 (c...nfection but increases the risk of developing West...NV) illness is caused due to a mosquito-borne viru...tional Institute of Allergy and Infectious Disease...
...ool in Scotland with the object of preventing chil.... Seminars are proposed to be conducted in schools...e reportedly resulting in the number of skin cance... Thomas Muir High School are reported to be going ...
...colleagues of the University of Texas Health Scien...he rat acts as an anti-depressant. Leptin is a hor...ulation. // The research was done on chronic unpre... that CUS rats had decreased levels of Leptin than...
Other Medicine News:Health News:CCR5 Mutation Confers Immunity Against HIV But Not Against West Nile Virus Illness 2Health News:Leptin, The Next Generation Antidepressant? 2
(Date:8/25/2008)...Y HILLS, Mass., Aug. 25 /- Joseph F. ... of Spherics, Inc. ("Spherics") for,the benefit of...l,intellectual property will be sold at a sealed b...tended release formulation of Levodopa-Carbidopa t...kinson,s disease, with global,sales estimated at a...
(Date:8/25/2008)...O, Calif., Aug. 25 /- Anthera Pharmac...company developing,anti-inflammatory drugs, today ...urrent Acute coronary events with Near-term Cardio...designed to examine the impact of,varespladib when...ute,Coronary Syndrome (ACS) event., The FRANCIS t...
(Date:8/22/2008)...men Enrolled in Trial Sponsored by Medical Researc...FirstCall/ -- Indevus,Pharmaceuticals, Inc. (Nasda...lment in Protocol MDP 301, a Phase III clinical tr...icrobicide for the prevention of HIV and other,sex...ed by the United,Kingdom,s Medical Research Counci...
(Date:8/22/2008)...E, Md., Aug. 22 /- Human Ge...ed that it has completed the,enrollment and initia... of,HGS-ETR1 (mapatumumab) in combination with the... first-line therapy in advanced non-small cell,lun.../cgi-bin/prnh/20080416/HGSLOGO ), "There is an u...
Breaking Medicine Technology:Spherics, Inc. Offers Extended Release Formulation for Sustained and Stable Levodopa Levels 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 2Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 1RIVAs Cutting Edge Technology To Help Intermountain Healthcare Enhance Medication Delivery Safety 14295 2HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 1HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 14292 22007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 12007 Procedural Survey Reveals a Two Year Increase in Age of Patients Seeking Cosmetic Surgery 14289 2Rodent study finds artificial butter chemical harmful to lungs 14287 1Rodent study finds artificial butter chemical harmful to lungs 14287 2
...Maintained Improvement in Personal and Social,Pe...07 /PRNewswire/ --,Longer-term treatment with IN..., a new once daily oral medication for,schizophr...ir,symptoms and maintain their improvements in p... data are from a large, open label, international,...
...nforce Astellas Commitment to Overcoming Critical,...many, April 02, 2007 /PRNewswire/ --Study results,...l Microbiology,and Infectious Diseases (ECCMID) sh...gal micafungin, both have the potential,to meet a ...s,hospital-acquired infections (HAIs). , Hospital-...
Other Medicine Technology:Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 2Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 3Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 4Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 5Study Suggests Invega Helps Patients With Schizophrenia Maintain,Symptom Control 6Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
The new PERIMOUNT Magna heart valve (bioprosthesis), with its true supra-annular design, offers optimal hemodynamics and flow characteristics for treatment of aortic heart valve disease.
... in high performance ultrasound design provides un...Echocardiography imaging requires superior spatial...er performance. The Terason Echo Ultrasound System...ecture, delivers a compact imaging platform withou...
...mplified In-office. Information. In real time. The...definitive indications of elevated vaginal fluid p...The innovative format is easy to use and delivers ...rub a swab containing unprocessed vaginal fluid ac...
For the quantitative determination of human MMP-9/NGAL Complex concentrations in cell culture supernates, serum,plasma, urine and saliva.
Medicine Products: